That's the discussion you have post p1a/b.
When the RC220 patent is lodged we want clinical validation in as many indications as possible - as quickly and for as little spend as possible.
- Forums
- ASX - By Stock
- Ann: Updated Strategy and Investor Presentation
That's the discussion you have post p1a/b.When the RC220 patent...
-
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.57 |
Change
-0.050(3.09%) |
Mkt cap ! $276.0M |
Open | High | Low | Value | Volume |
$1.62 | $1.65 | $1.54 | $109.8K | 68.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5906 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 75 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5906 | 1.565 |
1 | 950 | 1.560 |
2 | 1240 | 1.555 |
1 | 950 | 1.550 |
2 | 2240 | 1.545 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 75 | 1 |
1.605 | 5806 | 3 |
1.610 | 1954 | 2 |
1.615 | 391 | 1 |
1.620 | 2050 | 1 |
Last trade - 12.30pm 31/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online